- Home
- BPRE vs NOVTU Comparison
BPRE vs NOVTU Comparison
Compare BPRE & NOVTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$60.99
Company Overview
Basic Information| Metric | BPRE | NOVTU |
|---|---|---|
| Founded | N/A | N/A |
| Country | | United States |
| Employees | N/A | 3000 |
| Industry | | Industrial Machinery/Components |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | BPRE | NOVTU |
|---|---|---|
| Price | $16.62 | $60.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | N/A |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | N/A |
| 52 Week High | N/A | N/A |
Technical Indicators
Market Signals| Indicator | BPRE | NOVTU |
|---|---|---|
| Relative Strength Index (RSI) | 57.79 | 62.11 |
| Support Level | $15.89 | $59.58 |
| Resistance Level | $16.60 | $60.30 |
| Average True Range (ATR) | 0.49 | 0.50 |
| MACD | 0.08 | -0.18 |
| Stochastic Oscillator | 84.02 | 80.11 |
Price Performance
Historical Comparison BPRE
NOVTU
About NOVTU Novanta Inc. Tangible Equity Units
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.